Pediatrics

Metabolic Syndrome In Transgender Youth

Faculty Mentor’s Name: Dr. Kristin Dayton
Email: kristinjohnson23@ufl.edu 
Phone Number: (727) 409-1852 
Project Category: Clinical
International Component or Travel: No

Research Project Description:
This project aims to screen for metabolic syndrome in the pediatric transgender population undergoing hormone treatment at the UF Health Youth Gender Clinic. Additionally, the project aims to characterize the prevalence of various mood disorders in those with metabolic syndrome. We have received IRB approval for this chart review study, and it is ready for a medical student to begin collecting and analyzing data.

Demographic, Clinical Characteristics and Outcome of Ventilator-associated Tracheitits and Pneumonia in a Pediatric Population

Faculty Mentor’s Name: Dr. Silvana Carr
Email: s.carr1@peds.uf..edu 
Phone Number: (813) 312-4881
Project Category: Medical Record Review
International Component or Travel: No

Research Project Description:
Researchers at UF Health Shands Children’s Hospital plan to study the demographics, clinical features and outcome of pediatric patients (28 days-18 years of age) who were admitted to the NICU (Neonatal Intensive Care Unit), PICU (Pediatric Intensive Care Unit) and PCICU (Pediatric Cardiac Intensive Care Unit) and developed VAT/VAP while under positive pressure ventilation. Electronic medical records from January 01, 2015 through December 31,2019 will be reviewed. This information will help us to better understand the epidemiology, risk factors and outcome of VAT/VAP in children.

Epidemiology, clinical features and outcome of pediatric hematology and oncology patients with CLABSI

Faculty Mentor’s Name: Dr. Silvana Carr
Email: s.carr1@peds.uf..edu 
Phone Number: (813) 312-4881
Project Category: Medical Record Review
International Component or Travel: No

Research Project Description:
Study the epidemiology, clinical features and outcome of pediatric hematology and oncology patients with CLABSI, admitted to Shand’s pediatric onco-hematology unit during the period of Jan 01,2015 through December 31,2019. This information will help us to develop an anti-infective lock therapy guideline to this population

Identification and Evaluation of Obesity and its Comorbidities in University of Florida Primary Care

Faculty Mentor’s Name: Dr. Jacqueline Michel
Email: j.michel@ufl.edu
Phone Number: (715) 681-0692
Project Category: CQI
International Component or Travel: No

Research Project Description:
According to the CDC Childhood Obesity Facts, obesity affects roughly 13.7 million children and adolescents in the United States and is a growing health concern with lifelong associated morbidity and mortality. It is recommended that all children have blood pressure screening yearly starting at the age of 3. The American Diabetes Association recommends that overweight children with two risk factors (family history of type 2 diabetes mellitus, race/ethnicity at higher risk of diabetes mellitus, or signs of or conditions associated with insulin resistance) be screened with a fasting glucose every 2 years starting at 10 years of age or at the onset of puberty if this occurs before age 10. The National Heart, Lung and Blood institute recommends screening all children for dyslipidemia between the ages of 9-11 and 17-21, along with additional screening under certain conditions. However, the identification of and evaluation of obesity and its comorbidities are not always addressed at routine well child care. Furthermore there are currently no universal guidelines on defining, diagnosing and treating metabolic syndrome in children.

It is also widely documented that the prevalence of obesity is higher in children with autism spectrum disorder, and I am currently working on a project where I hypothesized that this population has a higher rate of metabolic syndrome. Our study found that metabolic syndrome is a significant health concern for children with autism spectrum disorder and highlights the importance of obesity prevention, treatment, and routine screening for metabolic syndrome in children with autism spectrum disorder.

This project will have multiple components with up to two students able to participate. As part of the Department of Pediatrics, students on this project will participate in a meeting series on academic output, culminating in an oral presentation to department chairs in Pediatrics and OB/GYN. There is no current funding for this project.

Identification and Evaluation of Obesity and its Comorbidities in University of Florida Primary Care
a. Development of UF Institutional Review Board (IRB) approved research plan
b. Development of a research database through REDCap (Research Electronic Data Capture)
c. Perform Chart Review of UF Pediatric Primary Care Charts assessing the identification and evaluation of obesity and its comorbidities
d. Perform literature review and identify the best intervention to improve the identification and evaluation of obesity and its comorbidities for UF Pediatric Patients
e. Implement the above intervention
f. Publication and presentation of findings (potential options include: an article discussing how a busy primary care provider can address this issue, an article reviewing findings of the quality improvement project identifying the intervention and if it improved patient care or identified health concerns in patients that would not otherwise be identified or how it affected HEDIS measures).

Identification and Evaluation of Obesity and Metabolic Syndrome in Children with Autism Spectrum Disorder or Intellectual Disability at the University of Florida

Faculty Mentor’s Name: Dr. Jacqueline Michel
Email: j.michel@ufl.edu
Phone Number: (715) 681-0692
Project Category: CQI
International Component or Travel: No

Research Project Description:
According to the CDC Childhood Obesity Facts, obesity affects roughly 13.7 million children and adolescents in the United States and is a growing health concern with lifelong associated morbidity and mortality. It is recommended that all children have blood pressure screening yearly starting at the age of 3. The American Diabetes Association recommends that overweight children with two risk factors (family history of type 2 diabetes mellitus, race/ethnicity at higher risk of diabetes mellitus, or signs of or conditions associated with insulin resistance) be screened with a fasting glucose every 2 years starting at 10 years of age or at the onset of puberty if this occurs before age 10. The National Heart, Lung and Blood institute recommends screening all children for dyslipidemia between the ages of 9-11 and 17-21, along with additional screening under certain conditions. However, the identification of and evaluation of obesity and its comorbidities are not always addressed at routine well child care. Furthermore there are currently no universal guidelines on defining, diagnosing and treating metabolic syndrome in children.

It is also widely documented that the prevalence of obesity is higher in children with autism spectrum disorder, and I am currently working on a project where I hypothesized that this population has a higher rate of metabolic syndrome. Our study found that metabolic syndrome is a significant health concern for children with autism spectrum disorder and highlights the importance of obesity prevention, treatment, and routine screening for metabolic syndrome in children with autism spectrum disorder.

This project will have multiple components with up to two students able to participate. As part of the Department of Pediatrics, students on this project will participate in a meeting series on academic output, culminating in an oral presentation to department chairs in Pediatrics and OB/GYN. There is no current funding for this project.
Project 2. Identification and Evaluation of Obesity and Metabolic Syndrome in Children with Autism Spectrum Disorder or Intellectual Disability at the University of Florida
a. Development of UF Institutional Review Board (IRB) approved research plan
b. Development of a research database through REDCap (Research Electronic Data Capture)
c. Perform Chart Review of UF Pediatric Charts assessing the identification and evaluation of obesity and metabolic syndrome in children with a diagnosis of autism or intellectual disability
d. Perform literature review and identify the best intervention to improve the identification and evaluation of obesity and metabolic syndrome in children with autism or intellectual disability
e. Implement the above intervention
f. Publication and presentation of findings (such as an article reviewing evidence of metabolic syndrome in children with autism and/or article reviewing findings of quality improvement project identifying the intervention and if it improved patient care or identified health concerns in patients that would not otherwise be identified).

Telehealth use in Pediatric Weight Management during COVID-19

Faculty Mentor’s Name: Dr. Angelina Bernier
Email:angelina@ufl.edu
Phone Number: (352) 265-7337
Project Category: Clinical
International Component or Travel: No

Research Project Description:
The goal of this project is to assess the implementation of telehealth-delivered pediatric weight management during COVID-19 and to identify potential disparities in accessing care among pediatric weight management patients before and during the COVID-19 pandemic. Researchers on this project will collect data pre and during COVID to determine differences in patient volume, show rates, use of telehealth, provision of training, implementation, RVU and then maintenance of telehealth post COVID. We will also assess how non-English interpretation services were made available, patient demographics and follow up. Students on this project will work through IRB submission, literature review, data entry and case reviews in addition to preparing a summary of outcomes measured.